Booster battle: Pfizer, Moderna go public with warning over escalating breakthrough cases HotAir

The question is not about how the vaccines are doing today, or last month, Moderna president Dr. Stephen Hoge tells NBC News. It s really how they are going to do this winter. The FDA and the Biden administration have a conundrum on their hands with this new public push from both Moderna and Pfizer regarding booster shots. Both companies went public yesterday with data that shows waning immune response from the initial rounds of vaccinations this winter and early spring, in Israel and in the US.

Should the US urge booster shots for its general population to prevent a wave of more serious breakthrough cases this winter? Or should it focus more on getting the first shot into the arms of people who have hesitated until now?

via hotair.com

This is what worries me. Maybe the US should both push boosters on general population and first shots on the vaccine hesitant.